DK0868188T3 - Kontraceptionskit til hunpattedyr bestående af en kombination af gestagen og estrogen - Google Patents

Kontraceptionskit til hunpattedyr bestående af en kombination af gestagen og estrogen

Info

Publication number
DK0868188T3
DK0868188T3 DK96946221T DK96946221T DK0868188T3 DK 0868188 T3 DK0868188 T3 DK 0868188T3 DK 96946221 T DK96946221 T DK 96946221T DK 96946221 T DK96946221 T DK 96946221T DK 0868188 T3 DK0868188 T3 DK 0868188T3
Authority
DK
Denmark
Prior art keywords
combination
contraception
progestogen
estrogen
kits
Prior art date
Application number
DK96946221T
Other languages
Danish (da)
English (en)
Inventor
Jan Endrikat
Bernd Duesterberg
Pia Reilhac
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK0868188T3 publication Critical patent/DK0868188T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK96946221T 1995-12-23 1996-12-20 Kontraceptionskit til hunpattedyr bestående af en kombination af gestagen og estrogen DK0868188T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19549264A DE19549264A1 (de) 1995-12-23 1995-12-23 Verfahren und Kit zur Kontrazeption
PCT/DE1996/002486 WO1997023228A2 (de) 1995-12-23 1996-12-20 Verfahren und kit zur kontrazeption bei weiblichen säugern, bestehend aus einer kombination von gestagen und estrogen

Publications (1)

Publication Number Publication Date
DK0868188T3 true DK0868188T3 (da) 2003-10-06

Family

ID=7781724

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96946221T DK0868188T3 (da) 1995-12-23 1996-12-20 Kontraceptionskit til hunpattedyr bestående af en kombination af gestagen og estrogen

Country Status (23)

Country Link
US (1) US6995149B1 (cs)
EP (1) EP0868188B1 (cs)
JP (1) JP2000502108A (cs)
KR (1) KR19990076685A (cs)
AT (1) ATE244567T1 (cs)
AU (1) AU716249B2 (cs)
BR (1) BR9612207A (cs)
CA (1) CA2241192A1 (cs)
CZ (1) CZ291743B6 (cs)
DE (2) DE19549264A1 (cs)
DK (1) DK0868188T3 (cs)
ES (1) ES2202498T3 (cs)
HU (1) HUP9901662A3 (cs)
IL (1) IL124472A (cs)
IS (1) IS4753A (cs)
MX (1) MX9804395A (cs)
NO (1) NO982902L (cs)
NZ (1) NZ330741A (cs)
PL (1) PL187180B1 (cs)
PT (1) PT868188E (cs)
SK (1) SK79298A3 (cs)
UA (1) UA59356C2 (cs)
WO (1) WO1997023228A2 (cs)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
CN1270521A (zh) * 1997-09-12 2000-10-18 美国家用产品公司 第一阶段包含孕激素/雌激素并且第二阶段包含孕激素的口服避孕制剂
EP1535618A1 (en) * 2003-11-26 2005-06-01 Schering Aktiengesellschaft Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions
DE102008036825A1 (de) * 2008-08-05 2010-02-11 Aicuris Gmbh & Co. Kg Schwangerschaftsvermeidung durch Gestagene
CA2740004A1 (en) 2008-10-08 2010-04-15 Agile Therapeutics, Inc. Transdermal delivery
EP2343963B1 (en) * 2008-10-08 2019-04-10 Agile Therapeutics, Inc. Transdermal delivery
CA2740005C (en) * 2008-10-08 2016-11-01 Agile Therapeutics, Inc. Transdermal delivery
WO2010111488A1 (en) 2009-03-27 2010-09-30 Agile Therapeutics, Inc. Transdermal delivery
JP5954736B2 (ja) * 2011-01-12 2016-07-20 国立大学法人 宮崎大学 難治性炎症性腸疾患の予防又は治療方法
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
RS62297B1 (sr) 2011-11-23 2021-09-30 Therapeuticsmd Inc Prirodne kombinovane hormonske supstitucione formulacije i terapije
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0368373A1 (en) 1988-10-13 1990-05-16 Akzo Nobel N.V. Multi-phase contraceptive preparation
NL9301562A (nl) * 1993-09-09 1995-04-03 Saturnus Ag Preparaat voor substitutietherapie.
DK0836506T4 (da) * 1995-06-07 2012-01-30 Ortho Mcneil Pharm Inc Transdermalt plaster til indgivelse af 17-deacetyl norgestimat alene eller i kombination med et østrogen
US6139873A (en) * 1996-07-10 2000-10-31 Cedars-Sinai Medical Center Combined pharmaceutical estrogen-androgen-progestin
US5770226A (en) * 1996-07-10 1998-06-23 Wake Forest University Combined pharmaceutical estrogen-androgen-progestin oral contraceptive
US6479475B1 (en) * 1996-07-26 2002-11-12 Wyeth Oral contraceptive
US5888543A (en) * 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
US5898032A (en) * 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
CA2348388A1 (en) * 1998-08-17 2000-02-24 The State Of Oregon Acting By And Through The State Board Of Higher Educ Ation On Behalf Of The University Of Oregon Gene regulating circadian clock function and photoperiodism

Also Published As

Publication number Publication date
EP0868188B1 (de) 2003-07-09
JP2000502108A (ja) 2000-02-22
MX9804395A (es) 1998-09-30
WO1997023228A2 (de) 1997-07-03
WO1997023228A3 (de) 1997-08-28
CZ9802000A3 (cs) 1998-11-11
HUP9901662A3 (en) 1999-11-29
SK79298A3 (en) 2000-06-12
AU716249B2 (en) 2000-02-24
PL327182A1 (en) 1998-11-23
PT868188E (pt) 2003-11-28
IS4753A (is) 1998-05-22
US6995149B1 (en) 2006-02-07
ATE244567T1 (de) 2003-07-15
NO982902D0 (no) 1998-06-22
AU1921997A (en) 1997-07-17
UA59356C2 (uk) 2003-09-15
HUP9901662A2 (hu) 1999-09-28
IL124472A0 (en) 1998-12-06
DE59610600D1 (de) 2003-08-14
CA2241192A1 (en) 1997-07-03
NZ330741A (en) 2000-03-27
CZ291743B6 (cs) 2003-05-14
DE19549264A1 (de) 1997-06-26
IL124472A (en) 2001-07-24
PL187180B1 (pl) 2004-05-31
ES2202498T3 (es) 2004-04-01
NO982902L (no) 1998-06-22
KR19990076685A (ko) 1999-10-15
BR9612207A (pt) 1999-07-13
EP0868188A2 (de) 1998-10-07

Similar Documents

Publication Publication Date Title
IS4753A (is) Getnaðarvarnaraðferð og -samstæða fyrir kvenkyns spendýr, sem inniheldur samsetningu með gestageni og estrógeni
TR199802705T2 (xx) Progestojen-anti-progestojen k�r�
BG104451A (en) Antiestrogen and progestin-containing peroral contraceptives
CY1105276T1 (el) Τριφασικο στοματικο αντισυλληπτικο
DK163209C (da) To- eller tretrinskombinationspraeparat til oral kontraception
NO976067D0 (no) Farmasöytisk kombinasjonspreparat, sett og fremgangsmåte for hormonell prevensjon
DK0491415T3 (da) Orale svangerskabsforebyggende midler med lavt østrogen
NL990003I1 (nl) Anticonceptiemiddel op basis van alleen progestogeen.
BR9710566A (pt) M-todo anticoncepcional monof sico e um kit compreendendo uma combina-Æo de uma progestina e estrog-nio
ATE91410T1 (de) Osmotische dosierungsform.
GR1001395B (el) Συν?έσεις και μέ?οδοι προς πραγματοποίηση αντισύλληψης.